Are you Dr. Dobrzanski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
41 Brewster Rd
Bristol, CT 06010Phone+1 860-585-3399Fax+1 860-585-3596
Summary
- Dr. David Dobrzanski, MD is an oncologist in Bristol, Connecticut. He is currently licensed to practice medicine in Connecticut.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
Albany Medical CenterResidency, Internal Medicine, 1986 - 1989
Uconn School Of MedicineClass of 1986
Certifications & Licensure
CT State Medical License 2008 - 2017
Publications & Presentations
PubMed
- 191 citationsTwo distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells.M. H. Corjay, D J Dobrzanski, James Way, Jean Viallet, Hagit Shapira
The Journal of Biological Chemistry. 1991-10-05 - 28 citationsAutologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patie...Mark J. Dobrzanski, Kathleen Rewers-Felkins, Imelda S. Quinlin, Khaliquzzaman A. Samad, Catherine A. Phillips
Clinical Immunology. 2009-12-01 - 9 citationsNeuromedin-B receptor transfected BALB/3T3 cells: signal transduction and effects of ectopic receptor expression on cell growthDavid Dobrzanski, Yoav Sharoni, Etsuko Wada, James F. Battey, Edward A. Sausville
Regulatory Peptides. 1993-06-11
